Transduodenal surgical ampullectomy for intra-ampullary papillary tubular neoplasm (IAPN): A case report

By -

 

Executive Summary

Intra-ampullary papillary tubular neoplasms (IAPNs) are rare but clinically significant tumors of the ampulla of Vater, representing approximately 0.5% of all gastrointestinal tumors. Characterized by a high potential for malignant transformation, they require early recognition and definitive management. While endoscopic papillectomy (EP) is often considered the first-line treatment for benign ampullary pathologies, it requires specialized expertise and equipment that may not be available in all clinical settings.

This briefing details a successful case of a 47-year-old male treated with Transduodenal Surgical Ampullectomy (TDA). The evidence suggests that TDA is a safe, feasible, and effective alternative to more radical procedures like pancreaticoduodenectomy (PD) and can serve as a primary treatment option in resource-limited environments or cases where endoscopic approaches are technically prohibited.

Overview of IAPN

IAPNs are tumoral intraepithelial neoplasias occurring within the ampulla. They are highly analogous to intraductal papillary and tubular neoplasms found in the pancreas or biliary tract.

Key Characteristics

  • Prevalence: Comprise 33% of primary ampullary tumors and 0.5% of all gastrointestinal tumors.

  • Morphology: Macroscopically, they typically show minimal exophytic growth on the duodenal surface but fill the intra-ampullary or ductal lumen, often resulting in a widened or irregular duodenal orifice.

  • Histology: Defined by papillary and/or tubular growth patterns with variable cellular lineage and a spectrum of dysplastic changes. More than 80% of cases exhibit both low-grade and high-grade dysplastic foci.

  • Prognosis: The prognosis for IAPNs is generally superior to that of other invasive carcinomas of the ampulla and pancreatic ductal adenocarcinoma.

Clinical Presentation and Diagnosis

The clinical symptoms of IAPN are often non-specific and primarily stem from the obstruction of the common bile duct or pancreatic duct.

Symptomatology

Common presentations include:

  • Abdominal pain (often dull-aching or progressive)

  • Jaundice and weight loss

  • Nausea, vomiting, and diarrhea

  • Potential for signs of cholestasis or cholangitis

Diagnostic Findings (Case Study)

The following data points were identified in a 47-year-old male patient presenting with a nine-month history of abdominal pain:

Diagnostic Tool

Findings

UGI Endoscopy

Bulky ampulla with growth arising from the ampulla of Vater.

EUS

Hyperechoic lesion at the ampulla; biopsy suggested low-grade dysplasia.

CECT Abdomen

Well-defined, homogenously enhancing lesion in the ampullary region with biliary obstruction.

Lab Results

Total Bilirubin: 4 mg/dL (Elevated); Alkaline Phosphatase: 262 IU/L (Elevated).

Tumor Markers

CA 19.9: 16.6 U/mL (Normal); CEA: 1.69 U/mL (Normal).


Surgical Management: Transduodenal Ampullectomy (TDA)

In cases where IAPN does not show infiltration or metastases, surgical resection is the recommended course of action.

The TDA Procedure

The transduodenal approach is considered less invasive than a full pancreaticoduodenectomy (Whipple procedure). The process involves:

  1. Exploration: Upper midline incision followed by exploration of the liver and abdominal cavity.

  2. Mobilization: A Kocher maneuver is performed to mobilize the duodenum and pancreatic head.

  3. Excision: A longitudinal duodenotomy allows for the identification and cannulation of the ampulla. The mass is excised via electro-cautery.

  4. Reconstruction: Separate openings for the pancreatic and bile ducts are created (duct-to-mucosa) using sutures, followed by a two-layer closure of the duodenal wall.

Pathological Confirmation

Post-operative histopathological examination (HPE) of the excised specimen (measured at 3 x 1.5 cm) revealed:

  • Polypoidal tumor composed of closely packed tubular glands.

  • Pseudostratified columnar epithelium with loss of polarity and moderate nuclear atypia.

  • Classification as high-grade IAPN.

  • A tumor-free stalk, indicating complete local resection.

Comparative Analysis of Treatment Modalities

The management of ampullary tumors involves weighing the benefits of endoscopic versus surgical interventions.

Procedure

Pros

Cons/Indications

Endoscopic Papillectomy (EP)

Low morbidity and mortality; recognized first-choice for benign pathology.

Requires high technical expertise; may not be available in all settings.

Transduodenal Ampullectomy (TDA)

Less invasive than PD; negative resection margins; safe and simple; high long-term efficacy.

Indicated for adenomas > 2cm or when EP is unavailable.

Pancreaticoduodenectomy (PD)

Radical clearance for invasive disease.

High surgical morbidity (25–50%) and mortality (~5%).

Clinical Insights

  • Safety: Studies indicate no significant difference in complication rates between TDA and EP groups (p=0.145).

  • Availability: In resource-limited settings where technically skilled manpower for endoscopic resection is lacking, TDA serves as a critical first-choice treatment.

  • Indicators for Surgery: Surgical resection is strongly indicated for adenomas greater than 2 cm in diameter, evidence of lymph node involvement, or ingrowth into the bile or pancreatic ducts.

Conclusion

IAPN is a rare but high-risk pathology that necessitates early diagnosis and surgical intervention. Transduodenal ampullectomy represents a safe, feasible, and effective surgical option. It provides a balanced approach between the high morbidity of radical resection (PD) and the technical limitations of advanced endoscopy (EP), ensuring a good prognosis and high patient satisfaction when applied in appropriate clinical contexts.